1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and preliminary efficacy of rogaratinib in combination with atezolizumab in a phase Ib/II study (FORT-2) of first-line treatment in cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (UC) and FGFR mRNA overexpression
    Meeting Abstract

    Rosenberg, J. E.; Gajate, P.; Morales-Barrera, R.; Lee, J. L.; Necchi, A.; Penel, N.; Zagonel, V.; Sierecki, M. R.; Piciu, A. M.; Ellinghaus, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma
    Meeting Abstract

    Oya, M.; Tamada, S.; Tatsugami, K.; Nakaigawa, N.; Osawa, T.; Kanayama, H. O.; Kondoh, C.; Sassa, N.; Nishimura, K.; Nozawa, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Safety and clinical activity of atezolizumab (atezo) + radium-223 dichloride (r-223) in 2L metastatic castration-resistant prostate cancer (mCRPC): Results from a phase Ib clinical trial
    Meeting Abstract

    Morris, M. J.; Fong, L.; Petrylak, D. P.; Sartor, A. O.; Higano, C. S.; Pagliaro, L. C.; Alva, A. S.; Appleman, L. J.; Tan, W.; Vaishampayan, U. N.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): Results from a phase III, prospective, multicenter study (CONDOR)
    Meeting Abstract

    Morris, M. J.; Carroll, P. R.; Saperstein, L.; Pouliot, F.; Josephson, D.; Wong, J. Y. C.; Pantel, A. R.; Cho, S. Y.; Gage, K.; Piert, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Biomarker analyses from the phase III CheckMate 214 trial of nivolumab plus ipilimumab (N plus I) or sunitinib (S) in advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Motzer, R. J.; Choueiri, T. K.; McDermott, D. F.; Powles, T.; Yao, J.; Ammar, R.; Papillon-Cavanagh, S.; Saggi, S. S.; McHenry, B. M.; Ross-Macdonald, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Effects of radiation therapy on clonal hematopoiesis
    Meeting Abstract

    Modlin, L. A.; Wijetunga, N. A.; Patel, M.; Gao, T.; Ptashkin, R.; Sullivan, M. R.; Kelly, D. W.; Caltabellotta, N.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The correlation between clinical benefit and financial cost of cancer drugs
    Meeting Abstract

    Mitchell, A. P.; Tabatabai, S.; Dey, P.; Ohn, J.; Curry, M. A.; Bach, P.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The association between drug industry payments and NCCN guideline panel membership
    Meeting Abstract

    Mitchell, A. P.; Mishra, A. A.; Dey, P.; Curry, M. A.; Trivedi, N. A.; Haddadin, M.; Rahman, M.; Winn, A. N.; Dusetzina, S.; Bach, P.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Results of a phase II trial of intense androgen deprivation therapy prior to radical prostatectomy (RP) in men with high-risk localized prostate cancer (PC)
    Meeting Abstract

    McKay, R. R.; Xie, W.; Fennessy, F. M.; Zhang, Z.; Lis, R.; Rathkopf, D. E.; Laudone, V. P.; Bubley, G.; Einstein, D. J.; Chang, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save